Drug Side Effects
Search
NEUROENDOCRINE CARCINOMA OF PROSTATE
NEUROENDOCRINE CARCINOMA OF PROSTATE
was reported 68 times
These drug classes are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF PROSTATE:
#
Drug
Count
0
Microtubule Inhibitor [EPC]
30
1
Androgen Receptor Inhibitor [EPC]
16
2
Topoisomerase Inhibitor [EPC]
15
3
Platinum-based Drug [EPC]
14
4
Corticosteroid [EPC]
8
5
Kinase Inhibitor [EPC]
2
6
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]
2
7
Aldosterone Antagonist [EPC]
1
8
Calcium Channel Blocker [EPC]
1
9
Dihydropyridine Calcium Channel Blocker [EPC]
1
10
Interleukin-12 Antagonist [EPC]
1
11
Interleukin-23 Antagonist [EPC]
1
12
Loop Diuretic [EPC]
1
13
Nucleoside Metabolic Inhibitor [EPC]
1
14
Osmotic Diuretic [EPC]
1
15
Osmotic Laxative [EPC]
1
16
Potassium Salt [EPC]
1
17
Programmed Death Ligand-1 Blocker [EPC]
1
18
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
19
alpha-Adrenergic Blocker [EPC]
1
20
beta-Adrenergic Blocker [EPC]
1
21
mTOR Inhibitor Immunosuppressant [EPC]
1